Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

25-hydroxyvitamin D

Reflects total vitamin D from sun exposure, food and supplements over the past few weeks to months. There is no agreed target for “optimal” levels, and this result alone cannot explain bone pain or similar symptoms.

Sample: Venous blood (serum)
Preparation: Fasting not required

When it is worth testing

Common cut-offs

Risk of deficiency< 12 ng/mL (< 30 nmol/L)
Possible insufficiency12–20 ng/mL (30–50 nmol/L)
Adequate for most people≥ 20 ng/mL (≥ 50 nmol/L)
Possible adverse effects> 50 ng/mL (> 125 nmol/L)

Related supplements

Vitamin D3 + vitamin K2 (MK-7) Test before supplementing

Common doses of 2000–5000 IU/day approach or exceed the usual adult upper limit of 4000 IU. Before long-term high-dose use, it is best to test once and set the dose by how deficient the person is. Preventive supplementation at the recommended amount does not need a test first.

Vitamin D3 + vitamin K2 (MK-7) Recheck while taking

On high-dose supplementation, you can recheck once at about 3 months to see whether you have reached the target and whether you are getting too much. Once the dose is stable, repeat testing is usually not needed.

Common drugs that affect this result

Antiepileptic drugs (Especially enzyme-inducing drugs such as phenytoin, phenobarbital and carbamazepine) · Vitamin D

These drugs speed up the breakdown of vitamin D. Low vitamin D is more common in people on long-term treatment, and it affects bone health. 25-hydroxyvitamin D can be checked periodically, and supplementation adjusted to the result.

Notes

References (3)
  1. Demay 2024 · J Clin Endocrinol Metab · Guideline, review or authoritative source — Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
  2. National Institutes of Health Office of Dietary Supplements 2025 · National Institutes of Health · Guideline, review or authoritative source — Vitamin D: Fact Sheet for Health Professionals
  3. Giustina 2024 · Endocr Rev · Guideline, review or authoritative source — Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
Open in the interactive app ›